Worldwide trends in cervical cancer incidence and mortality

Abstract Background Screening substantially reduces cervical cancer incidence and mortality. More than half of invasive cervical cancers are attributable to infrequent screening or not screening at all. The current study, My Body My Test (MBMT), evaluates the impact of mailed kits for self-collection of samples for human papillomavirus (HPV) testing on completion of cervical cancer screening in low-income, North Carolina women overdue for cervical cancer screening. Methods/design The study will enroll at least 510 US women aged 25–64 years who report no Pap test in the last 4 years and no HPV test in the last 6 years. We will randomize participants to an intervention or control arm. The intervention arm will receive kits to self-collect a sample at home and mail it for HPV testing. In both the intervention and control arms, participants will receive assistance in scheduling an appointment for screening in clinic. Study staff will deliver HPV self-collection results by phone and assist in scheduling participants for screening in clinic. The primary outcome is completion of cervical cancer screening. Specifically, completion of screening will be defined as screening in clinic or receipt of negative HPV self-collection results. Women with HPV-negative self-collection results will be considered screening-complete. All other participants will be considered screening-complete if they obtain co-testing or Pap test screening at a study-affiliated institution or other clinic. We will assess whether the self-collection intervention influences participants’ perceived risk of cervical cancer and whether perceived risk mediates the relationship between HPV self-collection results and subsequent screening in clinic. We also will estimate the incremental cost per woman screened of offering at-home HPV self-collection kits with scheduling assistance as compared to offering scheduling assistance alone. Discussion If mailed self-collection of samples for HPV testing is an effective strategy for increasing cervical cancer screening among women overdue for screening, this method has the potential to reduce cervical cancer incidence and mortality in medically underserved women at higher risk of developing cervical cancer. Trial registration ClinicalTrials.gov NCT02651883, Registered on 11 January 2016.

Download Full-text

Breast and cervical cancer incidence and mortality trends in Russia 1980–2013

Cancer Epidemiology ◽

10.1016/j.canep.2018.05.008 ◽

2018 ◽

Vol 55 ◽

pp. 73-80 ◽

Cited By ~ 8

Author(s):

Anton Barchuk ◽

Alexander Bespalov ◽

Heini Huhtala ◽

Tuvshinjargal Chimed ◽

Irina Laricheva ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Incidence ◽

Cervical Cancer Incidence ◽

Mortality Trends ◽

Breast And Cervical Cancer ◽

Incidence And Mortality

Download Full-text

Abstract 5287: Recent trends in racial and regional disparities in cervical cancer incidence and mortality

10.1158/1538-7445.am2017-5287 ◽

2017 ◽

Author(s):

Wonsuk Yoo ◽

Sangmi Kim ◽

Steven Coughlin ◽

Sejong Bae ◽

Edward Partridge ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Incidence ◽

Regional Disparities ◽

Cervical Cancer Incidence ◽

Incidence And Mortality ◽

Recent Trends

Download Full-text

PREDICTIONS OF CERVICAL CANCER INCIDENCE AND MORTALITY IN ENGLAND AND WALES

The Lancet ◽

10.1016/s0140-6736(86)92944-2 ◽

1986 ◽

Vol 327 (8479) ◽

pp. 495 ◽

Cited By ~ 76

Author(s):

Valerie Beral ◽

Margaret Booth

Keyword(s):

Cervical Cancer ◽

Cancer Incidence ◽

Cervical Cancer Incidence ◽

England And Wales ◽

Incidence And Mortality

Download Full-text

Erratum to: The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England

Cancer Causes & Control ◽

10.1007/s10552-013-0276-z ◽

2013 ◽

Vol 24 (11) ◽

pp. 2035-2035

Author(s):

Leonardo Simonella ◽

Karen Canfell

Keyword(s):

Cervical Cancer ◽

New Zealand ◽

Cancer Incidence ◽

Cervical Screening ◽

Cervical Cancer Incidence ◽

Screening Interval ◽

Incidence And Mortality ◽

The Impact

Download Full-text

Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: An administrative registry data analysis

10.21203/rs.3.rs-44815/v1 ◽

2020 ◽

Author(s):

Juliana Alexandra Hernández Vargas ◽

Paula Ximena Ramírez Barbosa ◽

Ana Milena Gil Quijano ◽

Ana María Valbuena García ◽

Lizbeth Acuña Merchán ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Incidence ◽

Public Health Problem ◽

Mortality Rates ◽

Eastern Region ◽

Global Public Health ◽

Cervical Cancer Incidence ◽

Mortality Trends ◽

Cross Sectional ◽

Incidence And Mortality

Abstract Background Cancer is widely recognized as a global public health problem. Breast, prostate and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical and prostate cancer across regions and municipalities in Colombia during 2018. Methods We performed a cross-sectional analysis with data from people with breast, prostate or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates were: 18,69 (CI 95%: 18,15–19,25) and 10,48 (CI 95%: 10,07–10,91); 11,34 (CI 95%: 10,90 − 11,78) and 7,58 (CI 95%: 7,22 − 7,96); 5,93 (CI 95%: 5,62 − 6,25) and 4,31 (CI 95%: 4,05 − 4,58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there were a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection and treatment in the country.

Download Full-text

Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: An administrative registry data analysis

10.21203/rs.3.rs-44815/v2 ◽

2020 ◽

Author(s):

Juliana Alexandra Hernández Vargas ◽

Paula Ximena Ramírez Barbosa ◽

Ana Milena Gil Quijano ◽

Ana María Valbuena García ◽

Lizbeth Acuña Merchán ◽

...

Keyword(s):

Cervical Cancer ◽

Cancer Incidence ◽

Public Health Problem ◽

Mortality Rates ◽

Eastern Region ◽

Global Public Health ◽

Cervical Cancer Incidence ◽

Mortality Trends ◽

Cross Sectional ◽

Incidence And Mortality

Abstract Background: Cancer is widely recognized as a global public health problem. Breast, prostate, and cervical cancer are among the most frequent types in developing countries. Assessing their incidence and mortality by regions and municipalities is important to guide evidence-based health policy. Our aim was to describe the incidence and mortality trends for breast, cervical, and prostate cancer across regions and municipalities in Colombia during 2018.Methods: We performed a cross-sectional analysis with data from people with breast, prostate, or cervical cancer, reported to the National Administrative Cancer Registry during 2018. A descriptive analysis was performed. Age-standardized incidence and mortality rates were estimated at national, regional, and municipal levels. Finally, we identify the regions and municipalities with significantly higher or lower incidence and mortality rates compared to national estimations. Results: Breast cancer was the most frequent type among all new cases and deaths in Colombia. Breast, prostate and cervical cancer incidence and mortality rates per 100,000 were: 18.69 (CI 95%: 18.15-19.25) and 10.48 (CI 95%: 10.07-10.91); 11.34 (CI 95%: 10.90-11.78) and 7.58 (CI 95%: 7.22-7.96); 5.93 (CI 95%: 5.62-6.25) and 4.31 (CI 95%: 4.05-4.58), respectively. Eastern region had both, incidence and mortality rates, significantly lower than national for all types of cancer. By municipalities, there was a heterogeneous pattern. Nonetheless, Agua de Dios (Cundinamarca), had one of the highest incidence rates for all types. Conclusions: We observed clear differences in cancer incidence and mortality across regions and municipalities, depending on each type of cancer. Our findings are important to improve screening coverage, early detection, and treatment in the country.

Download Full-text